|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Cardiology (Drs. Sueda, Fukuda, and Watanabe), Saiseikai Saijo Hospital, Saijo City, Japan; and the Department of Cardiology (Drs. Ochi, Kawada, Hayashi, and Uraoka), Kita Medical Association Hospital, Ozu, Japan.
Correspondence to: Shozo Sueda, MD, Department of Cardiology, Saiseikai Saijo Hospital, Tsuitachi 2691, Saijo City, Ehime Prefecture 793-0027, Japan
Study objectives: This study was performed to compare the results of accelerated exercise following mild hyperventilation and a standard acetylcholine (ACh) test for the induction of coronary artery spasm in patients with drug-induced coronary artery spasm.
Methods and results: The subjects were 74
patients with angiographically confirmed coronary artery spasm who were
examined using accelerated exercise (ie, exercise that
was accelerated every minute according to the protocol of Bruce and
Horsten) following mild hyperventilation and who were not receiving any
medication. ACh was injected in incremental doses of 20 µg and
50 µg into the right coronary artery and incremental doses of 20
µg, 50 µg, and 100 µg into the left coronary artery. Positive
coronary spasm was defined as
99% luminal narrowing. Accelerated
exercise following a mild hyperventilation test was as useful for
detecting evidence of ischemia as was an ACh test (48 patients
[64.9%] vs 49 patients [66.2%], respectively; not significant).
No difference was observed between ischemic changes on ECG as a result
of the newly combined method and the occurrence of ACh-induced spasm.
ACh-induced coronary vasospasm occurred in 61 patients (82.4%). In the
remaining 13 patients, intracoronary administration of ergonovine
provoked coronary spasms. No serious irreversible complications were
detected as a result of this newly combined method.
Conclusions: The effectiveness of our newly combined procedure is equivalent to that of an ACh test to diagnose patients with coronary artery spasm.
Key Words: accelerated exercise acetylcholine coronary spastic angina hyperventilation
This article has been cited by other articles:
![]() |
S. Sueda, H. Kohno, H. Fukuda, and T. Uraoka Did the Widespread Use of Long-Acting Calcium Antagonists Decrease the Occurrence of Variant Angina? Chest, December 1, 2003; 124(6): 2074 - 2078. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sueda, H. Kohno, H. Fukuda, K. Watanabe, N. Ochi, H. Kawada, and T. Uraoka Limitations of Medical Therapy in Patients With Pure Coronary Spastic Angina Chest, February 1, 2003; 123(2): 380 - 386. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |